Danaher’s vision for diagnostic excellence in infectious disease
4 Jun 2026
In this video, Kelly Sager, Vice President and Franchise Head, Infectious Disease and Acute Care for Danaher's diagnostics businesses, discusses the organization’s commitment to diagnostic excellence, a holistic approach to smarter test ordering, and improved patient outcomes.
Speaking at the ESCMID Global 2026 conference, Sager highlights Danaher's focus on diagnostic stewardship, not by simply just reducing the number of tests, but ensuring the right tests are performed for optimal care – ordering tests smarter, not fewer. Sager shares examples from this year's scientific symposium, such as the transformative impact of PCR screening on managing CPE (carbapenemase-producing Enterobacterales) outbreaks, helping health systems avoid costly mitigations.
Danaher’s drive for innovation is evident in its partnerships, including collaborations with Oxford Nanopore Technology for next-generation sequencing and MeMed for bacterial versus viral testing. Through these efforts, Danaher aims to support clinicians with faster answers, reduce uncertainty, and shape the future of diagnostics worldwide.
Interview recorded at ESCMID Global 2026.
